Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) (DIAMOND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03888066
Recruitment Status : Completed
First Posted : March 25, 2019
Last Update Posted : October 21, 2021
Information provided by (Responsible Party):
Vifor Pharma ( Vifor Pharma, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2, 2021
Actual Study Completion Date : September 2, 2021